CNCure biotech - South Korea

CNCure specializes in the development of radiopharmaceuticals and bacterial-based cancer therapies. The company's offerings include an innovative microbial platform for cancer therapy, molecular imaging spies for making informed decisions, and a radio-theranostics platform for simultaneous disease diagnosis and treatment, providing healthcare professionals with science and technology to diagnose diseases early and treat them effectively to improve health conditions.